BioSpace2d
FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues
Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...
Cambridge drugmaker wins city approval to put its sign above the treeline
The Cambridge drugmaker received approval on Thursday night from the city's Board of Zoning Appeal to display its name on a ...
FiercePharma2d
After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed
Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...
Yahoo2d
Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?
Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell in ...
Acsh.org7d
Moderna's mRNA Norovirus Vaccine Trials: To Hurl or Not to Hurl. That's the Endpoint.
Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But ...
Moderna Inc. stock underperforms Friday when compared to competitors
Shares of Moderna Inc. MRNA slipped 2.31% to $41.83 Friday, on what proved to be an all-around mixed trading session for the ...
Moderna Stock Is Struggling. BofA Doesn’t See Things Getting Better.
Analysts issued an Underperform rating for shares while reluanching coverage of large-cap U.S. pharma and biotech names.
Five things: Editas cuts, CVS shares, Moderna's name and the best birthday gift ever
Here are today's Five Things You Need to Know today in Boston business news, including Editas job cuts, CVS shares plunge, Moderna's name in the sky, the Boston tea party and the best birthday gift ...
Moderna Inc. stock outperforms competitors despite losses on the day
Shares of Moderna Inc. MRNA sank 0.09% to $42.82 Thursday, on what proved to be an all-around dismal trading session for the ...
Yahoo2d
FDA panel seeks more data on RSV vaccine safety in infants
The advisory committee, which met at the FDA’s request Thursday, did not reach a conclusion about the cause of a safety ...
The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...